Patient Guide: Phase 1/1b open-label, first-in-human study of HER2×CD3×CD28 trispecific T-cell engager (SAR443216) in participants with R/R HER2-expressing solid tumors

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 9 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05013554
Status: COMPLETED_NEXT_PHASE_UPCOMING
Condition: R/R HER2-expressing solid tumors
Phase: Phase I

Find a Study Location Near You

This study is available at 9 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Houston, Texas
  • Seoul,
  • Madrid,
  • • And 6 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily